Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$3.65−0.23 (-5.93%)
Close on Nov 17, 2026Market cap $525.20MP/E 24.8Yield –
Anbio Biotechnology cash
Cash and short-term investments held at the end of each period.
Anbio Biotechnology's cash was $11.90M at Dec 31, 2025. For fiscal 2025 it was $11.90M, up 1.2% from the year before. The highest annual figure on record is $11.90M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.90M | +1.2% |
| FY2024 | Dec 31, 2024 | $11.76M | +21.4% |
| FY2023 | Dec 31, 2023 | $9.69M | +36.4% |
| FY2022 | Dec 31, 2022 | $7.10M | +69.9% |
| FY2021 | Dec 31, 2021 | $4.18M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $11.90M | +184.6% |
| Q4 FY2024 | Dec 31, 2024 | $11.76M | – |
| Q4 FY2023 | Dec 31, 2023 | $9.69M | – |
| Q4 FY2022 | Dec 31, 2022 | $7.10M | – |
| Q4 FY2021 | Dec 31, 2021 | $4.18M | – |
See a number that looks wrong?